Screener
Castle Biosciences CSTL Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's operating margin?
- Castle Biosciences (CSTL) reported operating margin of -9.8% in Q1 2026.
- How has Castle Biosciences's operating margin changed year-over-year?
- Castle Biosciences's operating margin decreased by 146.5% year-over-year, from -4% to -9.8%.
- What is the long-term trend for Castle Biosciences's operating margin?
- Over 5 years (2020 to 2025), Castle Biosciences's operating margin has grown at a 3.6% compound annual growth rate (CAGR), from -10.4% to -12.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Castle Biosciences's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude